P19.03.B IMPLEMENTATION OF RESECT CATEGORIES FOR EXTENT OF RESECTION STRESS THE LONG-TERM CLINICAL BENEFIT OF SUPRAMAXIMAL CONTRAST ENHANCING RESECTION IN A RETROSPECTIVE COHORT OF NEWLY DIAGNOSED IDH WT GLIOBLASTOMA PATIENTS
Neuro-Oncology · 08.09.2023 · 25 (Supplement_2) · ii125-ii125
DOI: 10.1093/neuonc/noad137.421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 08.09.2023. Verfasst von C Gambacciani und 18 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND to assess the long-term benefit associated with supramarginal CE resection and to apply ReSECT criteria for extent of resection in patients with primary glioblastoma IDH wild-type. MATERIAL AND METHODS We performed a retrospective search in the institutional of Livorno Hospital for adult patients with primary GBM IDH wild-type. We assess residual tumor volumetry in the early post-operative magnetic resonance imaging by the 3dslicer software. We attributed EOR classes according to ReSECT criteria based on residual contrast and non-contrast enhancing tumor volumes. We performed multivariate analysis by Cox regression including main known prognostic factors and MGMT promoter status assessed by pyrosequencing. IDH wild-type status was defined on both IDH1 and IDH2 genes. RESULTS We identified 173 patients who underwent surgery for confirmed primary glioblastoma IDH wild-type in our institutions from 2016 and 2022. Male/female ratio was 1.6, median age at diagnosis 68 years old (yo) (range 30-83), median KPS before surgery was 80 (range 30-100) with no significant variation at the post-operative stage. Forty out of 173 (23%) patients received a supramarginal CE resection (class 1) in the whole cohort; prevalence of class 1 resection was the highest in the subgroup of patients aged ≤ 65 yo (27%) than the subgroup of >65 ≤ 75 yo (22%) and the subgroup of >75 yo (14%). The rate of class 1 resection was not different between patients with tumors located in the right and in left hemisphere (24% and 23% respectively). We analysed survival in patients treated with adjuvant RT-TMZ and found a significant longer OS in patients operated with resection class 1 (16.7 months) than other classes (p<0.0001). Long term benefit resulted the strongest in the subgroup of patients aged ≤ 65 yo (median OS 23.8 months). Multivariate analysis confirmed EOR according to the ReSECT criteria as the strongest independent predictor factor of OS (HR 0.6, p=0.004). CONCLUSION We efficiently implemented ReSECT criteria for EOR in our retrospective cohort of patients with primary GBM IDH wild-type. Supramarginal CE resection defined as no residual CE and ≤ 5 cm of nCE on the post-operative imaging emerged as the strongest predictive factor of survival.
Zitieren
APA
Gambacciani, C., Nizzola, M. G., Calvanese, F., Villanacci, F., Pieri, F., Grimod, G., Aquila, F., Scudieri, C., Cupini, S., Stasi, I., Zucchi, V., Giusti, A., Lastrucci, L., Vannozzi, F., Giuri, A., Farina, L., Pichiecchio, A., Stefano, A. L. D., & Santonocito, O. S. (2023). P19.03.B IMPLEMENTATION OF RESECT CATEGORIES FOR EXTENT OF RESECTION STRESS THE LONG-TERM CLINICAL BENEFIT OF SUPRAMAXIMAL CONTRAST ENHANCING RESECTION IN A RETROSPECTIVE COHORT OF NEWLY DIAGNOSED IDH WT GLIOBLASTOMA PATIENTS. Neuro-Oncology, 25(Supplement_2), ii125-ii125. https://doi.org/10.1093/neuonc/noad137.421
Vancouver
Gambacciani C, Nizzola MG, Calvanese F, Villanacci F, Pieri F, Grimod G, et al. P19.03.B IMPLEMENTATION OF RESECT CATEGORIES FOR EXTENT OF RESECTION STRESS THE LONG-TERM CLINICAL BENEFIT OF SUPRAMAXIMAL CONTRAST ENHANCING RESECTION IN A RETROSPECTIVE COHORT OF NEWLY DIAGNOSED IDH WT GLIOBLASTOMA PATIENTS. Neuro-Oncology. 2023;25(Supplement_2):ii125-ii125. doi:10.1093/neuonc/noad137.421
BibTeX
@article{Gambacciani2023,
author = {Gambacciani, C and Nizzola, M G and Calvanese, F and Villanacci, F and Pieri, F and Grimod, G and Aquila, F and Scudieri, C and Cupini, S and Stasi, I and Zucchi, V and Giusti, A and Lastrucci, L and Vannozzi, F and Giuri, A and Farina, L and Pichiecchio, A and Stefano, A L Di and Santonocito, O S},
title = {P19.03.B IMPLEMENTATION OF RESECT CATEGORIES FOR EXTENT OF RESECTION STRESS THE LONG-TERM CLINICAL BENEFIT OF SUPRAMAXIMAL CONTRAST ENHANCING RESECTION IN A RETROSPECTIVE COHORT OF NEWLY DIAGNOSED IDH WT GLIOBLASTOMA PATIENTS},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {Supplement_2},
pages = {ii125--ii125},
doi = {10.1093/neuonc/noad137.421}
}
EUVIMED